Report Ocean has published a new report on the Saudi Arabia Active Pharmaceutical Ingredient (API) Market, delivering an extensive analysis of key factors such as market restraint ...

The Global Active Pharmaceutical Ingredients Market achieved a valuation of $209.80 Billion in 2024 and is anticipated to exceed $445.7 Billion by 2035, reflecting a compounded annual growth rate ...

Key steps for pharmaceutical companies to meet FDA’s upcoming nitrosamine testing requirements and ensure product safety.

The global high potency API contract manufacturing market, valued at USD 8 billion in 2022, is poised for robust growth, with projections to reach USD 16 billion by 2032. This remarkable expansion, ...

Pakistan’s pharmaceutical embargo on Indian imports thus stands as both a calculated gamble and a potential blueprint for ...

US President Donald Trump's decision to impose punitive tariffs of 145% for pharmaceutical imports from China,1 effective since April 10, 2025, will pose substantial challenges towards global health ...

As the tariff situation continues to unfold in unexpected ways, the pharma industry must prepare for multiple eventualities.

How Ardena’s integrated services, nanomedicine expertise, and North American expansion are advancing drug development for ...

I. Key Takeaways - - The Secretary of Commerce is investigating the effects of imports of pharmaceuticals and pharmaceutical ingredients ...

The global hydrogen generation market size is projected to reach USD 317.39 billion by 2030, exhibiting a CAGR of 9.3% ...

Brooklyn-based Structify emerges from stealth with $4.1 million in seed funding to transform how businesses prepare data for AI, promising to save data scientists from the task that consumes 80% of ...